Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1

Schwarzer A, Oliveira M, Kleppa MJ, Slattery SD, Anantha A, Cooper A, Hannink M, Schambach A, Doerrie A, Kotylarov A, Gaestel M, Hembrough T, Levine J, Luther M, Stocum M, Stiles L, Weinstock DM, Liesa M, Kostura MJ. Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1. Mol Cancer Ther. 2023 Aug 30. doi: 10.1158/1535-7163.MCT-22-0718. Epub ahead of print. PMID: 37643767.


Related Posts